{"brief_title": "Experimental Medication For the Treatment of Generalized Anxiety Disorder", "brief_summary": "The purpose of this study is to determine whether an experimental anti-anxiety medication is effective in the treatment of Generalized Anxiety Disorder.", "detailed_description": "Protocol 04-001-01 The primary objective of the study is to assess, under controlled conditions, the safety and efficacy of an experimental anti-anxiety medication relative to placebo in subjects with generalized anxiety disorder (GAD). The secondary objective of the study is to study algorithms for discontinuation of an experimental anti-anxiety medication. Recruiting: Participants are currently being recruited and enrolled.", "condition": "Anxiety Disorder", "intervention_type": "Drug", "intervention_name": "experimental anti-anxiety drug", "criteria": "Inclusion Criteria: - Subjects 18 to 65 years of age will be eligible to participate if they satisfy the DSM-IV-TR criteria for the diagnosis of GAD. Exclusion Criteria: - No other primary psychiatric diagnosis besides GAD.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "65 Years", "healthy_volunteers": "No", "id": "NCT00097708.xml"}